SKI Market

A+| A| A-|

Indian Indices

Sensex

77,017.79 -251.61
( -0.33%)

Global Indices

Nasdaq

49,315.95 353.04
(0.72%)

Dow Jones

7,281.26 59.51
(0.82%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,219.44 -144.49
(-1.39%)

Forex

USD-INR

94.82 -0.13
(-0.14%)

EUR-INR

111.15 0.04
(0.04%)

GBP-INR

128.70 0.21
(0.16%)

JPY-INR

0.60 0.00
(0.59%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

C2C Advanced Systems Ltd

Industry : Engineering

BSE Code

ISIN Demat

Book Value()

93016

INE0U7V01015

127.6508352

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

C2C

26.63

768.08

EPS(TTM)

Face Value()

Div & Yield %

Back

Par Drugs & Chemicals standalone net profit rises 727.59% in the December 2025 quarter

Feb 11,2026

Net profit of Par Drugs & Chemicals rose 727.59% to Rs 4.80 crore in the quarter ended December 2025 as against Rs 0.58 crore during the previous quarter ended December 2024. Sales rose 37.23% to Rs 29.34 crore in the quarter ended December 2025 as against Rs 21.38 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	29.34	21.38	37
OPM %	20.62	6.64	-
PBDT	7.37	1.68	339
PBT	6.44	0.77	736
NP	4.80	0.58	728

77,017.79 -251.61 ( -0.33%)

49,315.95 353.04 (0.72%)

7,281.26 59.51 (0.82%)

59,594.47 309.55 (0.52%)

10,219.44 -144.49 (-1.39%)

94.82 -0.13 (-0.14%)

111.15 0.04 (0.04%)

128.70 0.21 (0.16%)

0.60 0.00 (0.59%)